| Lori Schuerman, MPH, DNP,APNP, PMHNP | |
|
305 Steele St, Algoma, WI 54201-1266 | |
| (920) 333-0333 | |
| (276) 835-4792 |
| Full Name | Lori Schuerman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 305 Steele St, Algoma, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861015737 | NPI | - | NPPES |
| 10170 | Medicaid | WI | |
| 10170 | Other | WI | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0808X | Registered Nurse - Psychiatric/mental Health | 231921 (Wisconsin) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 10170 (Wisconsin) | Primary |
| Entity Name | Oak Medical Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669910345 PECOS PAC ID: 0042595175 Enrollment ID: O20170331001848 |
News Archive
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.
Federal officials say they will revamp strategies for dealing with bioterrorism and pandemic flu because efforts to develop medical solutions have lagged, the Los Angeles Times reports. They "announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies." The makeover includes plans to hasten manufacturing time and improve surveillance to detect such threats more quickly.
Dr. Bernard Th-baud lives in two very different worlds. As a specialist in the Stollery Children's Hospital's Neonatal Intensive Care Unit at the Royal Alexandra Hospital, he cares for tiny babies, many of whom struggle for breath after being born weeks before they are due.
Genomic Health, Inc. today reported financial results and business progress for the quarter and year ended December 31, 2012.
› Verified 7 days ago
| Entity Name | Sherman Counseling Management Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235251349 PECOS PAC ID: 8921338187 Enrollment ID: O20191001002490 |
News Archive
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.
Federal officials say they will revamp strategies for dealing with bioterrorism and pandemic flu because efforts to develop medical solutions have lagged, the Los Angeles Times reports. They "announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies." The makeover includes plans to hasten manufacturing time and improve surveillance to detect such threats more quickly.
Dr. Bernard Th-baud lives in two very different worlds. As a specialist in the Stollery Children's Hospital's Neonatal Intensive Care Unit at the Royal Alexandra Hospital, he cares for tiny babies, many of whom struggle for breath after being born weeks before they are due.
Genomic Health, Inc. today reported financial results and business progress for the quarter and year ended December 31, 2012.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lori Schuerman, MPH, DNP,APNP, PMHNP 305 Steele St, Algoma, WI 54201-1266 Ph: (920) 333-0333 | Lori Schuerman, MPH, DNP,APNP, PMHNP 305 Steele St, Algoma, WI 54201-1266 Ph: (920) 333-0333 |
News Archive
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.
Federal officials say they will revamp strategies for dealing with bioterrorism and pandemic flu because efforts to develop medical solutions have lagged, the Los Angeles Times reports. They "announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies." The makeover includes plans to hasten manufacturing time and improve surveillance to detect such threats more quickly.
Dr. Bernard Th-baud lives in two very different worlds. As a specialist in the Stollery Children's Hospital's Neonatal Intensive Care Unit at the Royal Alexandra Hospital, he cares for tiny babies, many of whom struggle for breath after being born weeks before they are due.
Genomic Health, Inc. today reported financial results and business progress for the quarter and year ended December 31, 2012.
› Verified 7 days ago
Ellen Knipfer, MSN, RN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 815 Jefferson St, Algoma, WI 54201 Phone: 920-487-3496 |